Furthermore, Lünemann and colleagues (75) found that a small percentage of IFNγ-producing CD4 T cells specific for the EBV latent protein EBNA-1 cross-recognize MBP in both MS patients and healthy controls, their frequency being higher in MS patients. This evidence concerns the gene IFNG and myeloid sarcoma.